HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Vall d'Hebron Institut de Recerca
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (11)
2023
-
Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: Addition of 67 new patients
Journal of Medical Genetics, Vol. 60, Núm. 7, pp. 644-654
-
Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response
Frontiers in Immunology, Vol. 14
2020
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11
2019
-
Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1020-1030
2018
2016
-
Analysis of plasminogen genetic variants in multiple sclerosis patients
G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079
2015
-
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
Clinica Chimica Acta, Vol. 438, pp. 67-69
-
Influence of the LILRA3 deletion on multiple sclerosis risk: Original data and meta-analysis
PLoS ONE, Vol. 10, Núm. 8
-
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Annals of Neurology, Vol. 77, Núm. 3, pp. 447-457
2014
-
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles
Neurology: Neuroimmunology and NeuroInflammation, Vol. 1, Núm. 4
2011
-
Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice
Journal of Immunological Methods, Vol. 371, Núm. 1-2, pp. 170-173